Skip to main content
. Author manuscript; available in PMC: 2014 Apr 21.
Published in final edited form as: Allergy. 2008 Sep;63(9):1148–1155. doi: 10.1111/j.1398-9995.2008.01684.x

Figure 6.

Figure 6

Recombinant and ASM-derived CCL11 degraded in co-culture with HLMC. (A) The concentration of CCL11 in day 1, 3, and 7 ASM culture supernatants alone and co-cultured with HLMC lysates in the proportion of HLMC: ASM 1 : 2-1 : 16 (n = 3; P < 0.001), (B) co-cultured with whole HLMC after sensitization and/or activation (n = 6, P < 0.001) and (C) the % recovery of recombinant CCL11 after incubation with whole HLMC and lysates for 2 h ± increasing concentrations of leupeptin. *P < 0.05 paired t-test. Data are presented as mean ± SEM for three donors.